Celgene
In David Abrams's portfolio · Abrams Capital Management
Ticker CELG
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Abrams Capital Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q4 2019 | Sell | 0 | |
| Q3 2019 | No change | 6,752,869 | 18.8% |
| Q2 2019 | No change | 6,752,869 | 17.0% |
| Q1 2019 | Buy | 6,752,869 | 17.9% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.